Healthcare provider profile · identity verified

Mark J Schultz, MD

Family Practice · SPRINGFIELD, MO · NPI 1265477517

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	415	116
Rosuvastatin Calcium	Rosuvastatin Calcium	376	113
Atorvastatin Calcium	Atorvastatin Calcium	321	108
Amlodipine Besylate	Amlodipine Besylate	305	94
Lisinopril	Lisinopril	301	93
Gabapentin	Gabapentin	237	73
Metoprolol Succinate	Metoprolol Succinate	214	63
Eliquis	Apixaban	204	31
Metformin Hcl Er	Metformin Hcl	203	61
Tamsulosin Hcl	Tamsulosin Hcl	201	57
Pantoprazole Sodium	Pantoprazole Sodium	181	63
Tramadol Hcl	Tramadol Hcl	156	38
Bupropion Xl	Bupropion Hcl	155	42
Famotidine	Famotidine	143	38
Tizanidine Hcl	Tizanidine Hcl	139	33
Furosemide	Furosemide	137	46
Allopurinol	Allopurinol	130	41
Carvedilol	Carvedilol	127	37
Citalopram Hbr	Citalopram Hydrobromide	125	30
Escitalopram Oxalate	Escitalopram Oxalate	125	36
Losartan Potassium	Losartan Potassium	120	39
Pravastatin Sodium	Pravastatin Sodium	116	32
Jardiance	Empagliflozin	106	24
Simvastatin	Simvastatin	106	34
Omeprazole	Omeprazole	100	36
Trazodone Hcl	Trazodone Hcl	97	37
Potassium Chloride	Potassium Chloride	96	35
Metoprolol Tartrate	Metoprolol Tartrate	93	31
Montelukast Sodium	Montelukast Sodium	90	29
Fluticasone Propionate	Fluticasone Propionate	87	31
Pregabalin	Pregabalin	86	21
Duloxetine Hcl	Duloxetine Hcl	82	24
Farxiga	Dapagliflozin Propanediol	81	18
Irbesartan	Irbesartan	78	19
Spironolactone	Spironolactone	76	20
Metformin Hcl	Metformin Hcl	74	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	22
Mounjaro	Tirzepatide	70	14
Olmesartan Medoxomil	Olmesartan Medoxomil	70	18
Rybelsus	Semaglutide	69	suppressed
Sertraline Hcl	Sertraline Hcl	69	21
Hydralazine Hcl	Hydralazine Hcl	68	21
Albuterol Sulfate Hfa	Albuterol Sulfate	63	28
Ozempic	Semaglutide	63	15
Clopidogrel	Clopidogrel Bisulfate	62	25
Fluoxetine Hcl	Fluoxetine Hcl	62	suppressed
Buspirone Hcl	Buspirone Hcl	61	11
Donepezil Hcl	Donepezil Hcl	60	16
Ropinirole Hcl	Ropinirole Hcl	60	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	27
Valacyclovir	Valacyclovir Hcl	59	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	58	12
Hydrochlorothiazide	Hydrochlorothiazide	57	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	56	11
Triamcinolone Acetonide	Triamcinolone Acetonide	55	25
Ondansetron Odt	Ondansetron	48	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	18
Clonazepam	Clonazepam	45	11
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	45	16
Xarelto	Rivaroxaban	44	suppressed
Alprazolam	Alprazolam	43	11
Lorazepam	Lorazepam	40	19
Memantine Hcl	Memantine Hcl	40	suppressed
Telmisartan	Telmisartan	40	suppressed
Finasteride	Finasteride	39	15
Meloxicam	Meloxicam	39	14
Baclofen	Baclofen	38	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	14
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Tradjenta	Linagliptin	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Diazepam	Diazepam	31	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	31	suppressed
Anastrozole	Anastrozole	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	29	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Ketoconazole	Ketoconazole	27	14
Prazosin Hcl	Prazosin Hcl	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Dutasteride	Dutasteride	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	12
Novolog Flexpen	Insulin Aspart	25	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Atenolol	Atenolol	24	suppressed
Fenofibrate	Fenofibrate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	12
Ezetimibe	Ezetimibe	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Dutasteride-Tamsulosin	Dutasteride/Tamsulosin Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Levemir Flexpen	Insulin Detemir	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Etodolac	Etodolac	19	suppressed
Ibandronate Sodium	Ibandronate Sodium	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	11
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Prednisone	Prednisone	17	13
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Topiramate	Topiramate	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Primidone	Primidone	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	13	13
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Midodrine Hcl	Midodrine Hcl	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Guanfacine Hcl	Guanfacine Hcl	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Metaxalone	Metaxalone	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Probenecid-Colchicine	Probenecid/Colchicine	11	suppressed
Repatha Sureclick	Evolocumab	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error